The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,026.00
Bid: 12,008.00
Ask: 12,012.00
Change: 674.00 (5.94%)
Spread: 4.00 (0.033%)
Open: 11,890.00
High: 12,096.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Date   Source Headline
18th Dec 201512:41 pmRNSTAGRISSOT (OSIMERTINIB) POSITIVE CHMP OPINION
18th Dec 201512:41 pmRNSBRILIQUE (TICAGRELOR) POSITIVE EU CHMP OPINION
18th Dec 201512:40 pmRNSCHMP ISSUES POSITIVE OPINION ON LESINURAD FOR GOUT
18th Dec 20157:00 amRNSATLANTIC TRIAL SUPPORTS CLINICAL ACTIVITY
17th Dec 20152:08 pmRNSASTRAZENECA COMPLETES ACQUISITION OF ZS PHARMA
17th Dec 20157:00 amRNSAZ INVESTS IN ACERTA PHARMA TO ENHANCE GROWTH
16th Dec 20157:12 amRNSAZ ACQUISITION OF TAKEDA'S RESPIRATORY BUSINESS
15th Dec 20153:06 pmRNSAZ COMPLETES AGREEMENT WITH PERRIGO
14th Dec 20157:56 amRNSDiscussions with Acerta Pharma BV
2nd Dec 20157:00 amRNSLate-Stage Pipeline Conference Call
1st Dec 20152:00 pmRNSBlocklisting Interim Review
1st Dec 20151:00 pmRNSTotal Voting Rights
23rd Nov 20157:00 amRNSAZ enters agreement w/ Perrigo for Entocort in US
13th Nov 20153:06 pmRNSAZD9291 Approved by the US FDA
11th Nov 20157:30 amRNSASTRAZENECA PRICES A $6 BILLION BOND ISSUE
6th Nov 20157:00 amRNSAZ acquires ZS Pharma to strengthen CVMD portfolio
5th Nov 20157:02 amRNS3rd Quarter Results
4th Nov 20159:00 amRNSNotice of Results
2nd Nov 20151:01 pmRNSTotal Voting Rights
27th Oct 20155:50 pmRNSDirector/PDMR Shareholding
26th Oct 20157:00 amRNSFDA AD COM RECOMMENDS THE APPROVAL OF LESINURAD
16th Oct 20157:00 amRNSSaxa/dapa FDC Complete Response Letter from FDA
7th Oct 20157:00 amRNSASTRAZENECA COMPLETES DIVESTMENT OF CAPRELSA
1st Oct 20154:15 pmRNSTotal Voting Rights - Replacement
1st Oct 20152:00 pmRNSDirector/PDMR Shareholding
28th Sep 20152:30 pmRNSDirector/PDMR Shareholding
28th Sep 20152:30 pmRNSDirector/PDMR Shareholding
4th Sep 20157:00 amRNSUS FDA APPROVES EXPANDED INDICATION FOR BRILINTA
1st Sep 201511:30 amRNSTotal Voting Rights
1st Sep 20157:04 amRNSAstraZeneca and Valeant to partner on brodalumab
28th Aug 20154:00 pmRNSDirector/PDMR Shareholding
24th Aug 20157:00 amRNSAstraZeneca appoints Dr Sean Bohen
3rd Aug 20153:00 pmRNSTotal Voting Rights
30th Jul 20157:01 amRNSHalf Yearly Report
29th Jul 20159:00 amRNSNotice of Results
27th Jul 201511:00 amRNSConfirmation of Change in ADS Ratio
27th Jul 20157:00 amRNSAstraZeneca agreement with Genzyme on Caprelsa
22nd Jul 20157:00 amRNSAstraZeneca commences Phase II Trial
17th Jul 201511:00 amRNSHolding(s) in Company
17th Jul 20157:05 amRNSAZ completes agreement with Tillotts for Entocort
14th Jul 20157:00 amRNSIRESSA approved by US FDA
9th Jul 20157:32 amRNSAgreement with Tillotts on Entocort
1st Jul 201511:00 amRNSTotal Voting Rights
26th Jun 201512:00 pmRNSChange in ADS ratio
25th Jun 201511:30 amRNSPublication of Prospectus
16th Jun 20152:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20153:00 pmRNSHolding(s) in Company
1st Jun 20153:00 pmRNSTotal Voting Rights
1st Jun 20153:00 pmRNSAstraZeneca PLC - Blocklisting Interim Review
26th May 20157:01 amRNSUPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.